Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Transfusions During Surgery May Increase Risk of Pneumonia

By HospiMedica International staff writers
Posted on 10 Feb 2015
Patients who receive red blood cell (RBC) transfusions during coronary artery bypass grafting (CABG) surgery are at an increased risk of developing pneumonia, according to a new study.

Researchers at the University of Michigan Health System (Ann Arbor, USA) examined data on 16,182 patients who underwent CABG surgery between 2011 and 2013 in 33 hospitals participating in the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative. More...
Among participants in the study group, 39.9% received RBC transfusions and 3.6% developed pneumonia, with a significant association found between RBC transfusion and the occurrence of pneumonia.

The researchers found that risk of developing pneumonia increased with volume of RBC transfused; patients receiving one or two units of RBCs had double the odds of developing pneumonia compared to patients not receiving transfusion, while those who received six units or more had a 14-fold increased odds of developing pneumonia. The dose-dependent relationship was consistent across clinical subgroups and was not affected by other blood products, such as platelets. The study was presented at the annual meeting of the Society of Thoracic Surgeons (STS), held during January 2015 in San Diego (CA, USA).

“Pneumonia is a known risk following CABG surgery, and developing it has been shown to significantly increase a patient's risk of morbidity and mortality,” said lead author and study presenter Donald Likosky, PhD. “Patients should receive red blood cell transfusions based on clinical need. Surgical teams may have opportunities to reduce the need for transfusions among patients, thereby reducing the risk of secondary complications.”

Blood transfusions may cause transient immune suppression, thus increasing the susceptibility to infection, although the mechanism remains elusive. Another concern is that after transfusion macrophages lose their migratory ability in response to chemotactic stimuli, and also produce more prostaglandin. There is also an association between the length of storage of transfused RBCs and postoperative pneumonia, since various immunosuppressive substances are released from white blood cell granules during blood storage, contributing to transfusion-induced immunomodulation.

Related Links:

University of Michigan Health System



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.